“… She had two normal deliveries in 1987 and earlier this year, both very early, one at 35 weeks and the second at 33 weeks. Her LMP [last menstrual period] was 3rd October.”
“5. Our Policy in Chester in 1991 (which was agreed by all the Consultants in post at that time) was to administer Betamethasone only to those women in whom premature labour had been diagnosed as opposed to being possible or likely. The diagnosis of labour is made by the concurrence of regular painful uterine contractions and cervical dilatation. If the relevant criteria for the diagnosis of labour were present, then Betamethasone was administered and a Ritodrine drip commenced to try and delay delivery for sufficiently long to allow the Betamethasone to exert its beneficial effect. One would be hoping to delay delivery by 24 hours, but this is not always possible.”
“6 Conclusions 6.1 Implications for current practice This overview of randomised trials provides ample evidence that antenatal treatment with 24 mg betemethasone, or 24 mg dexamethasone, or 2 g hydrocortisone is associated with a significant reduction in the risks of neonatal respiratory distress. This reduction is of the order of 40 to 60 per cent and is independent of gender. Furthermore, the benefit of antenatal corticosteroids appears to apply to babies born at all gestational ages at which respiratory distress syndrome may occur. While the greatest benefits are seen in babies delivered more than 24 hours and less than 7 days after commencement of therapy, babies delivered before or after this optimum period also appear to benefit. This reduction in the risk of respiratory distress is accompanied by reductions in periventricular haemorrhage and necrotizing enterocolitis. This in turn results in a reduced mortality rate and in a reduction of the cost and duration of neonatal care. These benefits are achieved without any detectable increase in the risk of maternal, fetal, or neonatal infection, even in the presence of prolonged rupture of the membranes. Antenatal corticosteroid therapy does not increase the risk of stillbirth. 6.2 Implications for future research The benefits of antenatal corticosteroids have been established. No further trials are necessary with the exception of certain specific situations (such as pre-eclampsia) or to establish other dosages or routes of administration. Specifically, a trial to establish the correct dose of drugs to use in multiple pregnancy would be helpful. …”
“Summary. Continuing differences of opinion among obstetricians and neonatalogists about the place of corticosteroid administration before preterm delivery have prompted us to carry out a systematic review of the relevant controlled trials using methods designed to minimize systemic and random error. Data from 12 controlled trials, involving over 3000 participants, show that corticosteroids reduce the occurrence of respiratory distress syndrome overall and in all the subgroups of trial participants that we examined. This reduction in respiratory morbidity was associated with reductions in the risk of intraventricular haemorrhage, necrotizing enterocolitis and neonatal death. There is no strong evidence suggesting adverse effects of corticosteroids. The risks of fetal and neonatal infection may be raised if they are administered after prolonged rupture of the membranes, but this possibility is not substantiated by the results of the trials. The available data on long-term follow-up suggest that the short-term beneficial effects of corticosteroids may be reflected in reduced neurological morbidity in the longer term.”
“Discussion This overview of radomized trials of antenatal corticosteroid administration … has shown that corticosteroid administration leads to statistically and clinically significant reductions in neonatal morbidity and mortality, and that these are very unlikely to be outweighed by unwanted effects of these drugs … Overall, the reduction in the odds of neonatal respiratory morbidity is of the order of 40 – 60%. Further, the beneficial effects of antenatal corticosteroids appear to apply to babies born at all gestational ages at which respiratory distress syndrome may occur, and regardless of whether or not there has been prelabour rupture of the membranes. Although babies born 24 h and 7 days after beginning steroid administration may well benefit most from prophylaxis, the evidence suggests that babies born outside this optimum period can also benefit. There is no evidence to support the view that the gender of the baby modifies these effects. Indeed, we have been unable to identify any subgroup of babies at risk of respiratory morbidity for which thee are data to justify a conclusion that corticosteroids have no beneficial effect. The clear-cut reduction in the risk of respiratory distress is, as far as we can judge from the admittedly limited data available, accompanied by reductions in periventricular haemorrhage and necrotizing enterocolitis. All of this results in a reduced early neonatal mortality rate and reductions in the duration, and thus the costs, of hospital neonatal care. … A number of possible short-term and long-term risks of antenatal corticosteroid administration have been considered. … The immunosuppressive effects of corticosteroids could result in an increased susceptibility to fetal, neonatal or maternal infection, or to a delay in its recognition. Over the 11 years following the introduction of corticosteroids for fetal lung maturation in England and Wales, there were two maternal deaths from septicaemia associated with their use. … It is these two deaths that underlie the opposition of some British obstetricians to the use of corticosteroids for fetal lung maturation. In the presence of intact membranes, there is no clear evidence of an increase in the risk of maternal, fetal or neonatal infection. In the presence of prolonged rupture of the membranes, the absolute risk of fetal and neonatal infection may be greater, but again, controlled trials provide no strong evidence that corticosteroids increase this risk. … … It is important to recognize that the neonatal respiratory distress syndrome is common in infants of mothers with pre-eclampsia delivered pre-term: for example, it affected 36% of babies of women with pregnancy-induced hypertension in the placebo arm of the Collaborative Group trial … In the light of the available data, it would seem reasonable to use corticosteroids to reduce this considerable neonatal morbidity, provided the commitment to early delivery implied by corticosteroid treatment is carried through. Those obstetricians who remain uncertain that the demonstrable advantages of this policy would be outweighed by possible disadvantages in hypertensive women, or in other circumstances, should collaborate in further ramdomized trials to provide evidence on which to base their practice more firmly.”
“ANTENATAL CORTICOSTEROIDS TO PREVENT RESPIRATORY DISTRESS SYNDROME 1. INTRODUCTION Respiratory distress syndrome (RDS) affects 40-50% of babies born before 32 weeks. Evidence has been available since 1972 that the administration of corticosteroids prior to preterm delivery reduces the incidence of RDS. However, the use of antenatal corticosteroid therapy has been hesitant. An audit of preterm babies born in district general hospitals at a gestational age of less than 31 weeks in 1992 revealed that only 35% had antenatal exposure to corticosteroid therapy. 2. EFFECTIVENESS A meta-analysis of fifteen randomised controlled trials indicates that antenatal corticosteroid therapy reduces the incidence of RDS. There is an associated reduction in the risk of neonatal death and intraventricular haemorrhage. The efficacy of neonatal surfactant therapy is enhanced by antenatal exposure to corticosteroids. There is evidence of a benefit in all major sub-groups of preterm babies irrespective or race or gender. … TREATMENT DELIVERY INTERVAL The effect of treatment is optimal if the baby is delivered more than 24 hours and less than seven days after the start of treatment. However, there is a trend toward a benefit in babies delivered before and after the optimal treatment interval has elapsed. … 3. REPEATED DOSES It is important to emphasise that all evidence concerning safety and immediate and long-term side effects is derived from the randomized trials where a single course of treatment was administered. There are no randomized trials of repeated doses of antenatal corticosteroid therapy. The practice of repeating the course of treatment weekly has arisen in cases where the risk or preterm delivery persists or recurs following the initial treatment. The theoretical risks of this approach include some long-term effects on cognitive or neurological development that did not occur in the randomized trials which dealt with single courses of treatment only. … … 6. INDICATIONS FOR ANTENATAL CORTICOSTEROID THERAPY Every effort should be made to initiate antenatal corticosteroid therapy in women between 24 and 36 weeks’ gestation with any of the following: Threatened preterm labour Antepartum haemorrhage Preterm rupture of the membranes Any condition requiring elective preterm delivery. …”
“5.14 The use of steroids with delivery between 24 hours and 7 days after administration of the first dose reduces the odds of RDS by about 62% according to the Cochrane review last updated in 1996. In numerical terms 87 of 346 (25.1%) babies not achieving this will develop RDS compared with 44 of 382 (11.5%) who did receive full dose and deliver in this time interval. Delivery within 24 hours of the first dose reduced the rate of RDS by 30% (57 of 176 compared with 46 of 176). 5.15 It also reduces the risk of Periventricular haemorrhage by 52% using ultrasound diagnosis. Where steroids were not used then 26% of infants will have an intraventricular haemorrhage, whereas if steroids are given then 15.7% will have this complication. Long-term morbidity is reduced by 38% from 8% to 5.7% by the use of steroids.”
“My diagnosis was that she [Mrs Cowley] was not in labour. I was very junior and I followed routine departmental management policy. Betamethasone was not administered without a diagnosis of labour. So betamethasone would not have been considered in the light of my findings and diagnosis. But with 2 previous premature deliveries I decided to admit her for observation.”
“… Mrs Cowley’s symptoms settled and she slept through the night. Therefore the period of observation did not flag any indication for change in practice.”
“16/4/91 Slept well. Feels well. No further contraction pains just normal Braxton Hicks. No further show …”
“4. I first saw Mrs Cowley on16th April 1991 . She was 28 weeks gestation, in her fourth pregnancy, having had two previous premature labours, one at 35 weeks and one at 33 weeks. I have recorded in my Notes that in her first pregnancy, Mrs Cowley niggled into labour, but in the second pregnancy had a placental abruption which precipitated labour. My recollection is that at the time routine re-assessment of women presumed to be at risk of premature delivery was to undertake a speculum examination to avoid the introduction of infection and at this examination it was seen that there had been cervical change and that consequently this lady was at risk of premature delivery. 5. I prescribed Indomethacin to be given rectally and for oral Ritodrine to be given in a 10 milligram dose 2 hourly. Both these drugs are tocolytic agents. I also prescribed a cortico-steroid, Betamethasone. I did so in accordance with the policy in force at the time.”
“Baby active. Having occasional tightenings between Braxton Hicks [contractions]. Will inform us if she gets any different.”
“6. Later in the same day [i.e.16th April 1991 ], I was asked to review Mrs Cowley as she had had a small vaginal bleed. This was particularly concerning in view of her history of a previous pregnancy placental abruption. There was some concern about the fetal welfare, at this time, but the CTG was repositioned and there was no immediate concern with regard to performing an imminent delivery. 7. In view of the bleed, the lady was transferred to the Delivery Suite as further prolongation of the pregnancy in a lady who was bleeding would be inappropriate. An ultrasound scan was performed to confirm the presenting part and a further speculum examination done which showed bulging membranes. 8. Vaginal examination performed following this showed the cervix was fully dilated and the Paediatricians and Consultant on call were informed prior to awaiting spontaneous vaginal delivery.”
“5. Jamie’s birthweight was 1.24 kg. … At birth Jamie was blue and floppy, the heart rate was approximately 60 bpm and there was no respiratory effort. The Agpar score at one minute was 2. 6. At 2 minutes he was transferred to the Special Care Baby Unit, and … a tube was inserted into the trachea. Adrenaline … was given via the endotracheal tube. The heart rate rose to 90 bpm at 4 minutes of age and to 170 bpm at 6 minutes …. The Agpar score at 5 minutes … was 6. He became pink in colour at 8 minutes … and the Agpar score at 10 minutes … was 8. Mechanical ventilation was commenced … An intravenous dextrose infusion was commenced. 7. A capillary blood gas sample at one hour [was taken and analysed] … Chest X-ray at one hour … showed appearances compatible with respiratory distress syndrome (RDS) … An umbilical artery catheter was inserted. Blood cultures were taken and subsequently no growth of organisms was detected. At two hours … an arterial blood gas sample [was taken and analysed] … Antibiotic treatment with penicillin and neticillin was commenced and ethamsylate was given (to reduce the risk of intracranial bleeding). Vitamin K was given. A first dose of surfactant was given via the endotracheal tube. … 8. Over the following hours, Jamie’s condition was stable although he continued to require a high inspired oxygen concentration … On 17 April a second dose of surfactant was given via the endotracheal tube. The tube was changed for one of larger diameter and Jamie apparently tolerated this procedure well. At 1600 on the same day the medical records note that Jamie’s blood gas values were deteriorating. A continuing deterioration was noted in his condition subsequently, with a progressive decrease of oxygen saturation, increase in arterial carbon dioxide tension and cyanosis. There was no improvement following adjustment of the ventilation settings. Albumin … was given intravenously. A repeat X-ray showed severe respiratory distress syndrome with pulmonary interstitial emphysema. At 1645 the oxygen saturation was below 50% despite an inspired oxygen concentration of 100% and a peak inspiratory pressure of 35 cm. … 9. The arterial oxygen saturation continued to decrease and it was decided to change the endotracheal tube. … It was decided to use a 2.5 size tube. The tube insertion was successful and Jamie recovered slowly. Oxygen saturation improved for a short time but started then to decrease again. At 1815 it was decided to insert a larger endotracheal tube since there was an air leak with the smaller tube size. However, despite this there was a further deterioration in the respiratory function with increasing cyanosis and increasing arterial carbon dioxide tension despite maximal ventilatory settings. A chest x-ray showed changes consistent with severe respiratory distress syndrome, pulmonary interstitial emphysema and pulmonary haemorrhage. Jamie’s parents were informed of the critical nature of his condition, and he remained acutely unwell over the next few hours. 10. At 0200 on 18 April a 3rd dose of surfactant was given. The oxygen saturation improved over the following hours. … On the following day Jamie’s condition improved somewhat. A repeat chest X-ray showed increased shadowing within the right lung. … The plasma bilirubin concentration was moderately elevated … 11. On 20 April the peak ventilator pressure was reduced … but the inspired oxygen concentration remained high and Jamie was unstable on handling. … A cranial ultrasound scan was performed … and this was reported to show a “grade 2” bleed on the left and a “grade 2-3 bleed” on the right. (… grade 2 was equivalent to intraventricular haemorrhage and grade 3 indicated a haemorrhagic lesion within the brain … tissue). No major abnormalities of blood pressure were recorded. 12. On 21 April Jamie developed a mild metabolic acidosis and elevated carbon dioxide tension. The endotracheal tube was changed. A repeat chest x-ray showed a slight improvement, with both lungs expanded. On examination there was no significant abnormality. On 22 April a systolic heart murmur was noted and a persistent ductus arteriosus was suspected. Phototherapy for jaundice was continued. Intravenous nutrition was commenced. On 23 April some skin breakdown on the neck was noted. On 25th April Indomethacin was started for treatment of persistent ductus arteriosus. A chest X-ray on the following day showed resolving pulmonary interstitial emphysema. 13. On 29 April the endotracheal tube was changed and in the following hours Jamie’s ventilation improved. An abnormal heart sound (gallop rhythm suggestive of heart failure) was heard and frumeside was given. Jamie’s condition deteriorated overnight and he required 100% oxygen for an hour. His temperature was elevated at 38.8 degrees C and blood cultures were taken. These subsequently showed a growth of Gram positive cocci in all bottles, but this was interpreted as probably insignificant. Antibiotic treatment therapy was started. A repeat cranial ultrasound scan on 30 April showed a resolving grade 2 haemorrhage bilaterally and some ventricular dilatation, more on the left than on the right. The peak bilirubin concentration recorded for the entire admission was [moderately elevated] on 30 April and following treatment with phototherapy the bilirubin level declined rapidly [to an acceptable level] … 14. Over the following days Jamie’s condition gradually improved. Dexamethasone was started as treatment for bronchopulmonary dysplasia (chronic lung disease). On 7 May at 2015 Jamie suddenly deteriorated with a marked drop in oxygen saturation. The endotracheal tube was removed and an initial attempt at reintubation was unsuccessful. Jamie did not respond to bag and mask ventilation and during this procedure Jamie became bradycardic and external heart massage was commenced. A further endotracheal tube was inserted. Adrenaline was given via the tube and intravenously. Calcium gluconate, glucose, plasma and bicarbonate were also given. A prolonged period of external cardiac massage was required and the heart rare and oxygen saturation improved around 2035 pm. A chest x-ray was performed. Blood was obtained on aspiration of the endotracheal tube. … Jamie was ventilated with 100% oxygen at peak pressure of 27 cm. 15. Over the following days Jamie’s condition improved slightly. A repeat ultrasound scan of the brain showed resolving grade II haemorrhage bilaterally, with possibly parenchymal involvement on the right, but no enlargement of the ventricles. 16. On 14 May Jamie was seen by a cardiologist who diagnosed a clinically significant patent ductus arteriosus. Surgical ligation of the ductus arteriosus was recommended. On 17 May Jamie was transferred to Alder Hey Hospital for ligation of ductus. The procedure was performed without difficulty and the post-operative course was uncomplicated. Jamie was transferred back to Countess of Chester Hospital on the same day. 17. Following this Jamie remained ventilator dependent for a number of weeks. Repeated chest X-rays showed findings consistent with bronchopulmonary dysplasia. 18. On 2 June a further episode of infection occurred. Blood culture grew Acinetobacter organisms. A lumbar puncture showed clear cerebrospinal fluid. Antibiotic treatment was given and Jamie improved. A repeat cranial ultrasound scan on 7 June showed a resolved grade II haemorrhage bilaterally and moderate enlargement of the lateral ventricles. 19. On 9 June the endotracheal tube was finally removed and Jamie was able to breathe spontaneously with oxygen given by nasal prongs. On 17 July the prolonged course of dexamethasone was stopped. 20. In the following weeks there were repeated episodes of fever requiring treatment with antibiotics, an increased requirement of oxygen supply and feeding difficulties. It was decided to give a second course of dexamethasone which continued until November 1991. 21. In October and November there were intermittent episodes of fever and a urinary tract infection was diagnosed. This was treated with trimethoprim. A renal ultrasound examination showed normal findings. A micturating cystourethrogram (MCU) performed in 1992 showed bilateral reflux but no hydronephosis. On 22 October at a corrected age of about 3 months post term the head circumference was 38 cm and the weight was 3.72 kg. On 1 December Respiratory Syncitial Virus infection was diagnosed and Jamie was treated with ribovarin. 22. Jamie was eventually discharged from hospital on23 December 1991 still requiring additional inspired oxygen. He was seen in the follow-up department and he required readmission to hospital on several occasions with urinary tract infection and exacerbations of chronic lung disease. In January 1992 “jerky movements” were observed. Infantile spasms were suspected but clinical observation and EEG showed no abnormality. Because of Jamie’s severe chronic lung disease supplemental oxygen at home was required for over 2 years. 23. Subsequently it became sadly apparent that Jamie was developing signs of dyskinetic and spastic cerebral palsy affecting all four limbs with the legs more severely affected than the arms. The cerebral palsy has led to severe impairment of gross and fine motor function. In addition there was evidence of profound global developmental delay, severe hearing impairment and behavioural problems. 24. On29 April 1994 , at an age of 3 years, a magnetic resonance imaging (MRI) brain scan was performed. … In summary, the scan was reported to show marked dilatation of the lateral ventricles, with marked loss of Periventricular white matter particularly around the trigones (angles) of the lateral ventricles. In addition, there was patchy high T2 signal in the Periventricular white matter. There was abnormal T2 signal in the left globus pallidus and possibly in the inferior right pallidus. The cerebral peduncles, pons and medulla were small. In summary there is evidence of brain injury in several different regions, including the white matter adjacent to the lateral ventricles and the grey matter in the centre of the brain at the site of the basal ganglia and brain stem.”
“In 1991 there was no justification for a policy that restricted the use of cortico-steroids in cases of threatened pre-term labour. I am aware that there is literature showing that obstetricians were not using cortico-steroids as often as may be appropriate – but I have no knowledge of any reason for not using cortico-steroids in threatened pre-term labour. Any such practice was unreasonable in 1991. Cortico-steroids should have been administered to Mrs Cowley on 15th April. That should have been done at a stage when it was apparent that she was more likely to go into labour than she had been on 14th April. In my view, that was the position when she was seen by Dr Fishwick on 15th April. Against the background history of 2 premature deliveries, Mrs Cowley was experiencing contractions which were painful for some of the time. Although the cervix was not abnormal there had been a show of a blood-stained mucous plug. Putting these factors together, there was a likelihood of her going into premature labour and, therefore, she should have been given cortico-steroids on the 15th April.”
“[Mr Brennan] submitted that the judge had wrongly treated the Bolam test as requiring him to accept the views of one truthful body of expert professional advice even though he was unpersuaded of its logical force. He submitted that the judge was wrong in law in adopting that approach and that ultimately it was for the court, not for medical opinion, to decide what was the standard of care required of a professional in the circumstances of each particular case. My Lords, I agree with these submissions to the extent that, in my view, the court is not bound to hold that a defendant doctor escapes liability for negligent treatment or diagnosis just because he leads evidence from a number of medical experts who are genuinely of opinion that the defendant’s treatment or diagnosis accorded with sound medical practice. In the Bolam case itself, McNair J. … stated that the defendant had to have acted in accordance with the practice accepted as proper by a “responsible body of medical men”
“The inaccurate diagnosis of preterm labor has been a major obstacle to improving care, as nearly half of the women treated are not a true preterm labour. Meta-analysis of randomized controlled trials has indicated that 47 percent of mothers randomized to placebo deliver at term. DEFINITIONS Preterm labor is defined clinically as progressive cervical dilatation and/or effacement with regular uterine contractions prior to the completion of 37 weeks gestation … DIAGNOSIS The clinical diagnosis of true preterm labor has traditionally been based on the presence of uterine contractions and cervical changes. … Our clinical approach to preterm labor is summarized in Table 11-2. To prevent unnecessary drug therapy with potential adverse side effects, certain criteria should be adhered to before diagnosing preterm labor. These criteria involve gestational age assessment, uterine contractions, membrane status, and cervical assessment. Table 11-2. Clinical Questions in Preterm Labor 1 Is it a true or false labor? 2 Is there a need for immediate delivery? 3 Are there any contraindications to tocolysis? 4 Is there a treatable cause or causes present? … UTERINE CONTRACTIONS … Experience has shown that the rate of error in diagnosing preterm labor based on uterine contractions alone is 50 percent or more. … Frequency, regularity, or discomfort from contractions does not always reliably distinguish true preterm labor from false labor, nor does the period of time over which the contractions persist. … MEMBRANE STATUS If the membranes are ruptured in association with regular contractions, preterm labor is diagnosed. If the membranes are intact, cervical changes must be present in association with regular uterine contractions to diagnose preterm labor. CERVICAL STATUS Cervical changes have also been studied as predictors of preterm labor. … … Therefore, if the membranes are intact, cervical dilatation of at least 2 cm or effacement of at lease 80 percent is required to diagnose preterm labor. … INITIAL EVALUATION AND MANAGEMENT The objectives of management of preterm labor include minimization of perinatal morbidity and mortality and preservation of maternal health. In each individual case, the risk of continuing the pregnancy versus those of preterm delivery must be carefully considered. Since preterm delivery remains the major cause of perinatal morbidity and mortality, this condition should be managed by experienced personnel. Since these cases may present at any time, experienced personnel should be readily available. It is essential that all delivery units have written guidelines. The protocol outline in Figure 11-1 is an example. …”
“True preterm labor is preceded by a prodomal phase that may be reversible following simple non-specific measures. Patients with intact membranes who present with little or no cervical change should be observed on bed rest, avoiding the supine position.”
“There is slippage for a significant minority either way.”